| Symbol |
Name |
|
ACVR1
|
activin A receptor, type I
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
ALB
|
albumin
|
|
APOA1
|
apolipoprotein A-I
|
|
AQP5
|
aquaporin 5
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
C3
|
complement component 3
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
EDN1
|
endothelin 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FGA
|
fibrinogen alpha chain
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GSR
|
glutathione reductase
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
KDR
|
kinase insert domain receptor
|
|
MFN1
|
mitofusin 1
|
|
MFN2
|
mitofusin 2
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MYLK
|
myosin light chain kinase
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PROCR
|
protein C receptor, endothelial
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPD
|
surfactant protein D
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
TFF1
|
trefoil factor 1
|
|
TFF2
|
trefoil factor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBD
|
thrombomodulin
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TXN
|
thioredoxin
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
|
XDH
|
xanthine dehydrogenase
|
